The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia

Journal of the American Academy of Dermatology

Volumn 62, Issue 1, 2010, Pages 76-84

  Concannon, Rebecca ^a   Larcos, George S ^a,b   Veness, Michael ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

FDG PET; Merkel cell carcinoma; positron emission tomography

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD REVIEW; MERKEL CELL TUMOR; METASTASIS; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR;

AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEW SOUTH WALES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 71649109381     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.06.021     Document Type: Article

References (35)

1. Hodgson N.C. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 89 (2005) 1-4
2. Golan H., Volkov O., Linchinsky O., and Melloul M. FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scanning. Nucl Med Rev Cent East Eur 8 (2005) 135-136
3. Talbot J., Kerrou K., Missoum F., Grahek D., Aide N., Lumbroso J., et al. 6-(F-18)Fluoro-L-DOPA Positron Emission Tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-Deoxy-2-(F-18)Fluoro-D-glucose positron emission tomography or pentreotide-(111In) SPECT data. Mol Imaging Biol 7 (2005) 257-261
4. Grewal R.K., Pandit-Taskar N., Gonen M., and Larson S.M. F FDG PET for evaluation of Merkel cell carcinoma. J Nucl Med 46 Suppl2 (2005) abstract #137
5. Bedi C., Seel M., Ramdave S., Hicks R., and MacManus M. The use of FDG-PET scanning (PET) in the management of Merkel cell carcinoma (MCC). Int J Radiat Oncol Biol Phys 72 (2008) S107
6. Nguyen B.D. Positron emission tomographic imaging of Merkel cell carcinoma. Clin Nucl Med 27 (2002) 922-923
7. Wong C.O., Pham A.N., and Dworkin H.J. F-18 FDG accumulation in an octreotide negative Merkel cell tumor. Clin Positron Imaging 3 (2000) 71-73
8. Lin O., Thomas A., Singh A., and Greenspan B. Complementary role of positron emission tomography in Merkel cell carcinoma. South Med J 97 (2004) 1110-1112
9. Yao M., Smith R.B., Hoffman H.T., Funk G.F., Graham M.M., and Buatti J.M. Merkel cell carcinoma. Two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance. Am J Clin Oncol 28 (2005) 205-210
10. Iagaru A., Quon A., McDougall I.R., and Gambhir S.S. Merkel cell carcinoma: is there a role for 2-deoxy-2-(F-18)fluoro-D-glucose-positron emission tomography/computed tomography?. Mol Imaging Biol 8 (2006) 212-217
11. Belhocine T., Pierard G.E., Fruhling J., Letesson G., Bolle S., Hustinx R., et al. Clinical added-value of 18FDG PET in neuroendocrine-Merkel cell carcinoma. Oncol Rep 16 (2006) 347-352
12. Lampreave J.L., Benard F., Alavi A., Jimenez-Hoyuela J., and Fraker D. PET evaluation of therapeutic limb perfusion in Merkel's cell carcinoma. J Nucl Med 39 (1998) 2087-2090
13. Peloschek P., Novotny C., Mueller-Mang C., Weber M., Sailer J., Dawid M., et al. Diagnostic imaging in Merkel cell carcinoma: Lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol (2008) Dec 22. Epub ahead of print
14. Veness M.J., Morgan G.J., and Gebski V. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck 27 (2005) 208-216
15. Clark J.R., Veness M.J., and Gilbert R. O'Brien CJ, Gullane PJ. Merkel cell carcinoma of the head and neck: Is adjuvant radiotherapy necessary?. Head Neck 29 (2006) 249-257
16. Veness M.J., Palme C.E., and Morgan G.J. Merkel cell carcinoma: a review of management. Curr Opin Otolaryngol Head Neck Surg 16 (2008) 170-174
17. Allen P.J., Bowne W.B., Jaques D.P., Brennan M.F., Busam K., and Coit D.G. Merkel Cell Carcinoma: Prognosis and treatment of patients from a single institution. J Clin Oncol 23 (2005) 2300-2309
18. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 105 (1972) 107-110
19. Nghiem P., McKee P.H., and Haynes H.A. Merkel cell (cutaneous neuroendocrine) carcinoma. In: Sober A.J., and Haluska F.G. (Eds). American Cancer Society Atlas of Clinical Oncology: Skin Cancer (2001), BC Decker Inc, Hamilton, ON 127-141
20. Eng T.Y., Boersma M.G., Fuller C.D., Goytia V., Jones W.E., Joyner M., et al. A comprehensive review of the treatment of merkel cell carcinoma. Am J Clin Oncol 30 (2007) 624-636
21. Lewis K.G., Weinstock M.A., Weaver A.L., and Otley C.C. Adjuvant local irradiation for merkel cell carcinoma. Arch Dermatol 142 (2006) 693-700
22. Mojica P., Smith D., and Ellenhorn J.D.I. Adjuvant radiation therapy is associated with improved survival in merkel cell carcinoma of the skin. J Clin Oncol 25 (2007) 1043-1047
23. Voog E., Biron P., Martin J., and Blay J.Y. Chemotherapy for patients with locally advanced or metastatic merkel cell carcinoma. Cancer 85 (1999) 2589-2595
24. Gupta S.G., Wang L.C., Penas P.F., Gellenthin M., Lee S.J., and Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with merkel cell carcinoma. The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 142 (2006) 685-690
25. Warner R.E., Quinn M.J., Hruby G., Scolyer R.A., Uren R.F., and Thompson J.F. Management of merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol 15 (2008) 2509-2518
26. Willis A.I., and Ridge J.A. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head Neck 29 (2007) 979-985
27. Gollub M.J., Gruen D.R., and Dershaw D.D. Merkel cell carcinoma: CT findings in 12 patients. Am J Roentgenol 167 (1996) 617-620
28. Eftekhari F., Wallace S., Silva E.G., and Lenzi R. Merkel cell carcinoma of the skin: imaging and clinical features in 93 cases. Br J Radiol 69 (1996) 226-233
29. Anderson S.E., Beer K.T., Banic A., Steinbach L.S., Martin M., Friedrich E.E., et al. MRI of Merkel cell carcinoma: histologic correlation and review of the literature. Am J Roentgenol 185 (2005) 1441-1448
30. Durani B.K., Klein A., Henze M., Haberkorn U., and Hartschuh W. Somatostatin analogue scintigraphy in Merkel cell tumours. Br J Dermatol 148 (2003) 1135-1140
31. Guitera-Rovel P., Lumbroso J., Gautier-Gougis M., Spatz S., Mercier S., Margulis A., et al. Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases. Ann Oncol 12 (2001) 807-811
32. Kitajima K., Nakamoto Y., Okizuka H., Onishi Y., Senda M., Suganuma N., et al. Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors. Ann Nucl Med 22 (2008) 595-602
33. Larcos G., and Maisey M.N. FDG-PET screening for cerebral metastases in patients with suspected malignancy. Nucl Med Commun 17 (1996) 197-198
34. Garcia C., and Flamen P. Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era. Curr Opin Oncol 20 (2008) 275-279
35. Boellaard R., Oyen W.J., Hoekstra C.J., Hoekstra O.S., Visser E.P., Willemsen A.T., et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 35 (2008) 2320-2333